Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 27 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 10322069

    Restorative resin compositions and methods of use

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  2. US 10323070

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  3. US 10322113

    Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  4. US 10322171

    Vaccine with reduced enhancement of viral infection

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  5. US 10314950

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  6. US 10316073

    FCRN antagonists and methods of use

    The Board of Regents of the University of Texas System · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  7. US 10301320

    Compositions and methods of modulating 15-PGDH activity

    The Board of Regents of the University of Texas System · Granted May 28, 2019 · Expires May 23, 2039

    granted
  8. US 10300106

    Autophagy-inducing peptide analogs

    The Board of Regents of the University of Texas System · Granted May 28, 2019 · Expires May 23, 2039

    granted
  9. US 10300151

    Methods and systems for noninvasive fluorescence-based functional imaging of kidneys

    The Board of Regents of the University of Texas System · Granted May 28, 2019 · Expires May 23, 2039

    granted
  10. US 10292986

    Methods for treating epithelian mesenchymal transition related diseases

    The Board of Regents of the University of Texas System · Granted May 21, 2019 · Expires May 16, 2039

    granted
  11. US 10293002

    Methods and compositions for in vivo induction of pancreatic beta cell formation

    The Board of Regents of the University of Texas System · Granted May 21, 2019 · Expires May 16, 2039

    granted
  12. US 10293056

    Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted May 21, 2019 · Expires May 16, 2039

    granted
  13. US 10287262

    Eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted May 14, 2019 · Expires May 9, 2039

    granted
  14. US 10286065

    Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

    The Board of Regents of the University of Texas System · Granted May 14, 2019 · Expires May 9, 2039

    granted
  15. US 10287584

    Compounds and methods for the modulation of COMP

    The Board of Regents of the University of Texas System · Granted May 14, 2019 · Expires May 9, 2039

    granted
  16. US 10285956

    N-(2-aminoethyl) ethanolamine (AEEA) and analogs to treat hypertrophic scarring and liposomal topical delivery

    The Board of Regents of the University of Texas System · Granted May 14, 2019 · Expires May 9, 2039

    granted
  17. US 10285986

    Compounds and anti-tumor NQO1 substrates

    The Board of Regents of the University of Texas System · Granted May 14, 2019 · Expires May 9, 2039

    granted
  18. US 10285945

    Formation of stable submicron peptide or protein particles by thin film freezing

    The Board of Regents of the University of Texas System · Granted May 14, 2019 · Expires May 9, 2039

    granted
  19. US 10279042

    One-step processing of hydrogels for mechanically robust and chemically desired features

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted
  20. US 10280171

    Heterocyclic inhibitors of PTPN11

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted
  21. US 10279029

    Immunogenic compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted
  22. US 10279023

    Mucin-associated surface protein as a vaccine against chagas disease

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted
  23. US 10272184

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted
  24. US 10272158

    Compounds for treating biofilm infection

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted